Abstract:Objective: To establish a quantitative immunoassay method based on stable element labeling and inductively coupled plasma mass spectrometry (ICP-MS) for the detection of serum amyloid A (SAA) and evaluate its performance. Methods: An immunoassay system based on sandwich method was established with magnetic bead as carrier and holmium (Ho) as element tags. The binding ratio of hydrophilic streptavidin magnetic beads and biotinylated antibody, the amount of elemental antibody, and the reaction time were optimized to choose the optimal reaction conditions. According to the documents of Clinical and Laboratory Standards Institute (CLSI), the analytical performance was evaluated, including the limit of blank (LOB), linearity, accuracy, specificity, imprecision and interference test. Finally, 82 SAA plasma samples were collected after the turbidimetric inhibition immunoassay, and the newly established method was used for detection. Moreover, the detection results of the two methods were analyzed by Pearson correlation analysis. Results: The optimal binding ratio of hydrophilic streptavidin and biotinylated antibody was 1∶0.15, the amount of Ho-labeled antibody was 3 μl and the incubation time of the two reaction steps was 40 min and 30 min, respectively. The LOB was 0.6 ng/ml. The linearity was good within the range of 0-1 200 μg/L (R2=0.998 9, P<0.001). The inter-batch precision of high-value samples and low-value samples was 9.42% and 7.95%, respectively, and the intra-batch precision was 14.56% and 13.56%, respectively. The recovery was 96.01%-104.76%. The cross-reaction rates with procalcitonin (PCT) and C-reactive protein (CRP) were 0.45% and 0.015%, respectively. When the concentration of triglyceride≤35.5 mg/L, bilirubin≤0.52 mg/L and hemoglobin≤2.4 g/L, the interference bias was less than 10%. The results of 82 SAA plasma samples were 12.65 (4.45, 59.03) mg/L by ICP-MS immunoassay and 18.23 (9.33, 68.72) mg/L by turbidimetric inhibition immunoassay, respectively. The newly established system was well correlated with turbidimetric inhibition immunoassay (R2=0.983, P<0.001). Conclusion: The quantitative immunoassay for SAA with Ho as marker established in this study has high precision, good accuracy, high specificity, and wide linear range, which can meet the clinical testing requirements.

Immunoassay for Serum Amyloid A Using a Glassy Carbon Electrode Modified with Carboxy-Polypyrrole, Multiwalled Carbon Nanotubes, Ionic Liquid and Chitosan

Electrospun Poly-ε-caprolactone/Poly- l -lysine (PCL/PLL) Nanofibers as an Emergent Material for the Preparation of Electrochemical Immunosensor to Detect Serum Amyloid A

Electrochemical Immunosensor for the Sensitive Detection of Alzheimer’s Biomarker Amyloid‐β (1–42) Using the Heme‐amyloid‐β (1–42) Complex As the Signal Source

Reusable Voltammetric Immunosensor for Scd40l, a Biomarker for the Acute Coronary Syndrome, Using a Glassy Carbon Electrode Modified with a Nanocomposite Consisting of Gold Nanoparticles, Branched Polyethylenimine and Carboxylated Multiwalled Carbon Nanotubes

Molecularly Imprinted Sensor Based on Poly-O-phenylenediamine-hydroquinone Polymer for Β-Amyloid-42 Detection

Electrostatic Nanocage-Confined Probe for Electrochemical Detection of CA19-9 in Human Serum.

Ultrasensitive Immunosensor for Acrylamide Based on Chitosan/sno2-Sic Hollow Sphere Nanochains/gold Nanomaterial As Signal Amplification.

Determination of Α2,3-Sialylated Glycans in Human Serum Using a Glassy Carbon Electrode Modified with Carboxylated Multiwalled Carbon Nanotubes, a Polyamidoamine Dendrimer, and a Glycan-Recognizing Lectin from Maackia Amurensis

Development of electrode by using gold-platinum alloy nanopar¬ticles for electrochemical detection of serum amyloid A protein

Ultrasensitive photoelectrochemical immunosensor for the detection of amyloid β-protein based on SnO2/SnS2/Ag2S nanocomposites.

Electrochemical immunoassay for the carcinoembryonic antigen based on the use of a glassy carbon electrode modified with an octahedral Cu2O-gold nanocomposite and staphylococcal protein for signal amplification

Sensitive Electrochemical Immunosensor for Α-Synuclein Based on Dual Signal Amplification Using PAMAM Dendrimer-Encapsulated Au and Enhanced Gold Nanoparticle Labels

Highly Sensitive/selective 3D Nanostructured Immunoparticle-Based Interface on a Multichannel Sensor Array for Detecting Amyloid-Beta in Alzheimer's Disease

Amperometric Immunosensor For Carcinoembryonic Antigen Based On Poly(2,6-Pyridinediamine) Membrane And Gold Nanoparticles

Multianalyte Immunoassay Based on Insulating-Controllable PoPD Film at Arrayed Electrodes Integrated on a Silicon Chip.

Peptide-antifouling Interface for Monitoring Β-Amyloid Based on Electrochemiluminescence Resonance Energy Transfer.

Fe3O4@Au SERS tags-based lateral flow assay for simultaneous detection of serum amyloid A and C-reactive protein in unprocessed blood sample

Ultrasensitive electrochemical immunoassay based on cadmium ion-functionalized PSA@PAA nanospheres.

Highly efficient ratiometric electrochemiluminescence biosensor with amyloid aggregation as antifouling coating and g-C 3 N 4 as internal standard for carcinoembryonic antigen immunoassay

[Establishment and application of quantitative immunoassay method based on stable element labeling and inductively coupled plasma mass spectrometry]

A Glassy Carbon Electrode Modified with Graphene Nanoplatelets, Gold Nanoparticles and Chitosan, and Coated with a Molecularly Imprinted Polymer for Highly Sensitive Determination of Prostate Specific Antigen